Statement of Organization, Functions, and Delegations of Authority, 35936 [2013-14165]
Download as PDF
<![CDATA[
35936
Federal Register / Vol. 78, No. 115 / Friday, June 14, 2013 / Notices
(3) What are the key functions of the
B Reader certification and recertification examinations grading
system, and how should the
examinations be graded to accomplish
those functions? Should the general
approach currently used for grading 1 2
be changed and if yes, how and why?
(4) Should NIOSH consider
alternative approaches to maintenance
of B Reader certification besides
recertification examinations every 4
years? If so, what alternative approaches
would be both effective and desirable?
(5) NIOSH seeks to obtain materials,
including published and unpublished
reports and research findings that will
help to answer these questions. NIOSH
encourages respondents to provide these
materials.
References
1. Morgan RH [1979].Proficiency
Examination of Physicians for Classifying
Pneumoconiosis Chest Films. AJR 132:
803–808.
2. Wagner GR, Attfield MD, Kennedy RD,
Parker JE [1992]. The NIOSH B Reader
Certification Program-An Update Report. J
Occup Med 34(9):879–84.
Dated June 7, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2013–14147 Filed 6–13–13; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 78 FR 30307–30312,
dated May 22, 2013) is amended to
reorganize the Office of the Associate
Director for Science, Office of the
Director, Centers for Disease Control
and Prevention, and to revise the
functional statement for the Office of
Scientific Integrity, Office of the
Director, National Center for
Immunization and Respiratory Diseases.
Section C–B, Organization and
Functions, is hereby amended as
follows:
VerDate Mar<15>2010
17:03 Jun 13, 2013
Jkt 229001
Delete in its entirety the functional
statement for the Office of the Director
(CAS1), Office of the Associate Director
for Science (CAS), and insert the
following:
Office of the Director (CAS1). (1)
Directs, manages, and coordinates the
activities of the OADS; (2) develops
goals and objectives, provides
leadership, policy formation, scientific
oversight, and guidance in program
planning and development; and (3)
oversees functions of Office of Science
Quality, Office of Scientific Integrity,
Office of Technology and Innovation,
and Special Projects Activity.
After the title and function statement
for the Office of Scientific Integrity
(CASJ), Office of the Associate Director
for Science (CAS), insert the following:
Office of Technology and Innovation
(CASK). (1) Promotes and facilitates the
development of technology and
innovation throughout the spectrum of
scientific discovery; (2) provides
leadership and expertise to promote and
effect the timely transfer of knowledge
and technology for development of
products and processes that improve
public health; (3) manages CDC’s
intellectual property (e.g., patents,
trademarks, copyrights) and promotes
the transfer of new technology from
CDC research to the private sector; (4)
leads, develops, coordinates, and
manages policies and/or activities that
assure CDC intellectual property
transfer, scientific training and technical
assistance; (5) champions and facilitates
innovation, collaborations and
technology transfers among federal
scientists, laboratories, academia and
industry; (6) provides leadership and
oversight for innovation activities that
have the potential to transform the way
that CDC and the private sector improve
the public’s health; (7) provides
consultation and advice to the CDC
Office of the Director, Centers/Institute/
Offices, and programs related to
technology transfer and innovation; and
(8) maintains regular, open, and
responsive communication with the
CDC science community and other key
partners including CDC Office of
General Council, National Institute of
Health, Department of Health and
Human Services and United States
Patent and Trademark Office.
Delete in its entirety the functional
statement for the Office of Laboratory
Science (CVG14), Office of the Director
(CVG1), National Center for
Immunization and Respiratory Diseases
(CVG), and insert the following:
Office of Laboratory Science (CVG14).
(1) Provides leadership, expertise and
service in laboratory science; (2)
represents NCIRD’s interests in cross-
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
cutting laboratory services in OID which
include, but are not limited to,
laboratory information systems, quality
management systems and
bioinformatics; (3) ensures a safe
working environment in NCIRD
laboratories; and (4) collaborates
effectively with other centers and offices
in carrying out its functions.
Dated: June 6, 2013.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2013–14165 Filed 6–13–13; 8:45 am]
BILLING CODE 4163–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers CMS–10482]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
ACTION: Notice.
AGENCY:
SUMMARY: The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Comments must be received by
August 13, 2013:
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number (OCN). To be
assured consideration, comments and
DATES:
E:\FR\FM\14JNN1.SGM
14JNN1
]]>Agencies
[Federal Register Volume 78, Number 115 (Friday, June 14, 2013)]
[Notices]
[Page 35936]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14165]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 78 FR 30307-30312, dated May 22, 2013) is
amended to reorganize the Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention, and
to revise the functional statement for the Office of Scientific
Integrity, Office of the Director, National Center for Immunization and
Respiratory Diseases.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the functional statement for the Office of
the Director (CAS1), Office of the Associate Director for Science
(CAS), and insert the following:
Office of the Director (CAS1). (1) Directs, manages, and
coordinates the activities of the OADS; (2) develops goals and
objectives, provides leadership, policy formation, scientific
oversight, and guidance in program planning and development; and (3)
oversees functions of Office of Science Quality, Office of Scientific
Integrity, Office of Technology and Innovation, and Special Projects
Activity.
After the title and function statement for the Office of Scientific
Integrity (CASJ), Office of the Associate Director for Science (CAS),
insert the following:
Office of Technology and Innovation (CASK). (1) Promotes and
facilitates the development of technology and innovation throughout the
spectrum of scientific discovery; (2) provides leadership and expertise
to promote and effect the timely transfer of knowledge and technology
for development of products and processes that improve public health;
(3) manages CDC's intellectual property (e.g., patents, trademarks,
copyrights) and promotes the transfer of new technology from CDC
research to the private sector; (4) leads, develops, coordinates, and
manages policies and/or activities that assure CDC intellectual
property transfer, scientific training and technical assistance; (5)
champions and facilitates innovation, collaborations and technology
transfers among federal scientists, laboratories, academia and
industry; (6) provides leadership and oversight for innovation
activities that have the potential to transform the way that CDC and
the private sector improve the public's health; (7) provides
consultation and advice to the CDC Office of the Director, Centers/
Institute/Offices, and programs related to technology transfer and
innovation; and (8) maintains regular, open, and responsive
communication with the CDC science community and other key partners
including CDC Office of General Council, National Institute of Health,
Department of Health and Human Services and United States Patent and
Trademark Office.
Delete in its entirety the functional statement for the Office of
Laboratory Science (CVG14), Office of the Director (CVG1), National
Center for Immunization and Respiratory Diseases (CVG), and insert the
following:
Office of Laboratory Science (CVG14). (1) Provides leadership,
expertise and service in laboratory science; (2) represents NCIRD's
interests in cross-cutting laboratory services in OID which include,
but are not limited to, laboratory information systems, quality
management systems and bioinformatics; (3) ensures a safe working
environment in NCIRD laboratories; and (4) collaborates effectively
with other centers and offices in carrying out its functions.
Dated: June 6, 2013.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2013-14165 Filed 6-13-13; 8:45 am]
BILLING CODE 4163-18-M
